![]() |
Volumn 12, Issue 9, 2012, Pages 1099-1101
|
Heat shock proteins in cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA CRYSTALLIN;
CANCER VACCINE;
HEAT SHOCK PROTEIN;
HEAT SHOCK PROTEIN 27;
HEAT SHOCK PROTEIN 70;
HEAT SHOCK PROTEIN 90;
HEAT SHOCK PROTEIN 90 INHIBITOR;
HEAT SHOCK TRANSCRIPTION FACTOR 1;
IMMUNOMODULATING AGENT;
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;
MULTIPROTEIN COMPLEX;
ONCOPROTEIN;
PEPTIDE APTAMER;
TUMOR ANTIGEN;
APOPTOSIS;
CANCER CELL;
CANCER CHEMOTHERAPY;
CANCER PROGNOSIS;
CANCER RADIOTHERAPY;
CARCINOGENESIS;
CD4+ T LYMPHOCYTE;
CD8+ T LYMPHOCYTE;
CELL FUNCTION;
CELL PROLIFERATION;
CELL STRUCTURE;
CELL SURVIVAL;
DISTANT METASTASIS;
EDITORIAL;
ENERGY METABOLISM;
HEAT TOLERANCE;
HUMAN;
HYPERTHERMIC THERAPY;
IMMUNE RESPONSE;
IMMUNE SYSTEM;
IMMUNOGENICITY;
MALIGNANT TRANSFORMATION;
METASTASIS;
NEOPLASM;
OLIGOMERIZATION;
PHENOTYPE;
POLYPLOIDY;
PROTEIN EXPRESSION;
PROTEIN FOLDING;
PROTEIN FUNCTION;
PROTEIN PHOSPHORYLATION;
RNA INTERFERENCE;
SIGNAL TRANSDUCTION;
TUMOR GROWTH;
METABOLISM;
PATHOLOGY;
HEAT-SHOCK PROTEINS;
HSP70 HEAT-SHOCK PROTEINS;
HUMANS;
NEOPLASMS;
|
EID: 84867815944
PISSN: 15665240
EISSN: 18755666
Source Type: Journal
DOI: 10.2174/156652412803306738 Document Type: Editorial |
Times cited : (5)
|
References (0)
|